Pheon Therapeutics

United Kingdom · Founded 2015 · Privately Held (backing)

Developer of advanced cancer treatment intended for targeting hard-to-treat cancers. Pheon Therapeutics is based in United Kingdom and was founded in 2015. Its last known valuation is $173 million. It has raised $191 million.

Last price · $/share
—
Implied valuation
$172.7M
Total raised
$191.1M
Last round
—
What is Pheon Therapeutics worth?
$172.7Mlast known valuation
Free account
More of Pheon Therapeutics with a free account
  • ·The complete investor list: 11 names
  • ·Watch Pheon Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Pheon Therapeutics funding history

No rounds on record

No funding rounds for Pheon Therapeutics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

Pheon Therapeutics valuation

Pheon Therapeutics's last known valuation is $173 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.

How Pheon Therapeutics's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Pheon Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked about Pheon Therapeutics

What is Pheon Therapeutics worth?
Pheon Therapeutics's last known valuation is $172.7M.
How much has Pheon Therapeutics raised?
Pheon Therapeutics has raised $191.1M in total funding across its recorded rounds.